drug discovery

A unique collection of 2400 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening;

A unique collection of 280 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of 2010 small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;

A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 569 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9384 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research.

A unique collection of 485 PPI-related compounds for drug screening;

A unique collection of 2880 approved drugs for high throughput screening (HTS) and high content screening (HCS);

A collection of 27302 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

3400 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 610 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;

A unique collection of 2955 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 1385 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of 3230 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);

Well-chosen quantity: only contains 989 bioactive compounds after careful selection

A unique collection of 1855 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 425 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 750 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 4655 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 4221 natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening;